About: A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers
Creator	Rahman, Noorsaadah Chee, Chin Dabbagh, Ali Rasul, Ruhisy Shah, Kifayatullah Zakaria, Zabliza Muniandy, A Tamilarasi, M Won, Wui Wong, Wui
Source	Elsevier; PMC
abstract	Chitosan, as a biodegradable and biocompatible polymer, is characterized by anti-microbial and anti-cancer properties. It lately has received a widespread interest for use as the pulmonary particulate backbone materials of drug carrier for the treatment of infectious disease and cancer. The success of chitosan as pulmonary particulate drug carrier is a critical interplay of their mucoadhesive, permeation enhancement and site/cell-specific attributes. In the case of nanocarriers, various microencapsulation and micro-nano blending systems have been devised to equip them with an appropriate aerodynamic character to enable efficient pulmonary aerosolization and inhalation. The late COVID-19 infection is met with acute respiratory distress syndrome and cancer. Chitosan and its derivatives are found useful in combating HCoV and cancer as a function of their molecular weight, substituent type and its degree of substitution. The interest in chitosan is expected to rise in the next decade from the perspectives of drug delivery in combination with its therapeutic performance.
has issue date	2020-08-18(xsd:dateTime)
bibo:doi	10.1016/j.carbpol.2020.116800
has license	no-cc
sha1sum (hex)	8212a307841f7ad90a0f469f385cb8424a68b6b5
schema:url	https://doi.org/10.1016/j.carbpol.2020.116800
resource representing a document's title	A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers
has PubMed Central identifier	PMC7434482
schema:publication	Carbohydr Polym
resource representing a document's body	covid:8212a307841f7ad90a0f469f385cb8424a68b6b5#body_text
is schema:about of	named entity 'ENHANCEMENT' named entity 'PROPERTY' named entity 'RECEIVED' named entity 'WIDESPREAD' named entity 'OF INTEREST' named entity 'MATERIALS' named entity 'BASED' named entity 'MICROBIAL' named entity 'infection' named entity 'Chitosan' named entity 'Polymers' named entity 'anti-fungal' named entity 'liquid state' named entity 'H1299' named entity 'alveolar sacs' named entity 'MCF-7' named entity 'biocompatibility' named entity 'acetyl' named entity 'mannose' named entity 'biological properties' named entity 'permeation' named entity 'tight junction' named entity 'microparticles' named entity 'cell membrane' named entity 'spleen' named entity 'adhesion' named entity 'biodegradability' named entity 'tumor' named entity 'Quercetin' named entity 'chitosan' named entity 'mucoadhesive' named entity 'aerodynamic' named entity 'carbon dioxide' named entity 'cancer therapeutics' named entity 'PTX' named entity 'nanoparticles' named entity 'drug delivery' named entity 'phagocytosis' named entity 'P. aeruginosa' named entity 'chronic inflammation' named entity 'parenteral' named entity 'nanoparticles' named entity 'chitosan' named entity 'non-small cell lung cancer' named entity 'apoptotic death' named entity 'disintegrant' named entity 'mucociliary clearance' named entity 'lactose' named entity 'deacetylated' named entity 'anti-diabetic' named entity 'Goy' named entity 'anti-tubercular' named entity 'cancer cells' named entity 'polymer' named entity 'chitosan' named entity 'Chitosan' named entity 'adsorbed' named entity 'nasal cavity' named entity 'Inhalation' named entity 'larynx' named entity 'methotrexate' named entity 'drug targeting' named entity 'negatively charged' named entity 'metalloproteinase' named entity 'nanoparticles' named entity 'electrostatically' named entity 'lipid' named entity 'lactose' named entity 'arthropods' named entity 'Ngo' named entity 'infection' named entity 'Drug delivery' named entity 'anti-inflammatory' named entity 'positive charges'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software